
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Is the voltage-gated sodium channel β3 subunit (SCN3B) a biomarker for glioma?
Hengrui Liu, Jieling Weng, Christopher Huang, et al.
Functional & Integrative Genomics (2024) Vol. 24, Iss. 5
Closed Access | Times Cited: 18
Hengrui Liu, Jieling Weng, Christopher Huang, et al.
Functional & Integrative Genomics (2024) Vol. 24, Iss. 5
Closed Access | Times Cited: 18
Showing 18 citing articles:
Single-cell and bulk RNA sequencing analysis reveals CENPA as a potential biomarker and therapeutic target in cancers
Hengrui Liu, Miray Karsidag, Kunwer Chhatwal, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0314745-e0314745
Open Access | Times Cited: 4
Hengrui Liu, Miray Karsidag, Kunwer Chhatwal, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0314745-e0314745
Open Access | Times Cited: 4
ADME gene-driven prognostic model for bladder cancer: a breakthrough in predicting survival and personalized treatment
Haojie Dai, Xi Zhang, You‐Yang Zhao, et al.
Hereditas (2025) Vol. 162, Iss. 1
Open Access | Times Cited: 1
Haojie Dai, Xi Zhang, You‐Yang Zhao, et al.
Hereditas (2025) Vol. 162, Iss. 1
Open Access | Times Cited: 1
Development and experimental validation of dephosphorylation-related biomarkers to assess prognosis and immunotherapeutic response in gliomas
Hui Tang, Xuping Yang, Guoqian Li, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Hui Tang, Xuping Yang, Guoqian Li, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
SCN3B is an Anti-breast Cancer Molecule with Migration Inhibition Effect
Yinfeng Zhao, Jianzhong Ye, Yun Liang, et al.
Biochemical Genetics (2025)
Closed Access
Yinfeng Zhao, Jianzhong Ye, Yun Liang, et al.
Biochemical Genetics (2025)
Closed Access
Fatty acid metabolism related gene MECR contributes to the progression of prostate cancer
Yifan Liu, Lilin Wan, Yuxuan Chen, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Yifan Liu, Lilin Wan, Yuxuan Chen, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
PAR2 Serves an Indispensable Role in Controlling PAR4 Oncogenicity: The β-Catenin–p53 Axis
Priyanga Appasamy, Jeetendra Kumar Nag, Hodaya Malka, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2780-2780
Open Access
Priyanga Appasamy, Jeetendra Kumar Nag, Hodaya Malka, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2780-2780
Open Access
MEX3A promotes cell proliferation by regulating the RORA/β-catenin pathway in hepatocellular carcinoma
Pengxiang Ji, Yanping Zhang, Huiling Zhou, et al.
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 4
Closed Access
Pengxiang Ji, Yanping Zhang, Huiling Zhou, et al.
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 4
Closed Access
Discovery of a DNA repair-associated radiosensitivity index for predicting radiotherapy efficacy in breast cancer
Jianguang Lin, Hainan Yang, Rongfu Huang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Jianguang Lin, Hainan Yang, Rongfu Huang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Identification of M1 macrophage infiltration-related genes for immunotherapy in Her2-positive breast cancer based on bioinformatics analysis and machine learning
Shouyu Wang, Xiaoyan Wang, Jing Xia, et al.
Research Square (Research Square) (2025)
Closed Access
Shouyu Wang, Xiaoyan Wang, Jing Xia, et al.
Research Square (Research Square) (2025)
Closed Access
EFTUD2 is a promising diagnostic and prognostic indicator involved in the tumor immune microenvironment and glycolysis of lung adenocarcinoma
Ankang Yin, Yufan Xu, Xiyang Su, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Ankang Yin, Yufan Xu, Xiyang Su, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Exploring the regulatory role of CNPY3 as a prognostic biomarker on human glioma cell migration, invasion and immune infiltration
Lu Zhan, Fanyue Zeng, Jie Zheng, et al.
Cancer Biomarkers (2025) Vol. 42, Iss. 3
Closed Access
Lu Zhan, Fanyue Zeng, Jie Zheng, et al.
Cancer Biomarkers (2025) Vol. 42, Iss. 3
Closed Access
Analytical validation of the Belay Vantage™ assay for evaluation of MGMT promoter methylation using enzymatically converted tumorDNA from cerebrospinal fluid
Kala F. Schilter, Qian Nie, Jerry M. Adams, et al.
Cancer Genetics (2025)
Open Access
Kala F. Schilter, Qian Nie, Jerry M. Adams, et al.
Cancer Genetics (2025)
Open Access
Identification of M1 macrophage infiltration-related genes for immunotherapy in Her2-positive breast cancer based on bioinformatics analysis and machine learning
Shouyu Wang, Xiaoyan Wang, Jing Xia, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Shouyu Wang, Xiaoyan Wang, Jing Xia, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
The voltage-gated sodium channel β3 subunit modulates C6 glioma cell motility independently of channel activity
Hengrui Liu, Samir W. Hamaia, Lisa Dobson, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167844-167844
Open Access
Hengrui Liu, Samir W. Hamaia, Lisa Dobson, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167844-167844
Open Access
Molecular characteristics of early- and late-onset ovarian cancer: insights from multidimensional evidence
Yanting Shen, Jie Cheng, Qing Qing Ding, et al.
Journal of Ovarian Research (2025) Vol. 18, Iss. 1
Open Access
Yanting Shen, Jie Cheng, Qing Qing Ding, et al.
Journal of Ovarian Research (2025) Vol. 18, Iss. 1
Open Access
Multi-omics analysis unveils a four-gene prognostic signature in esophageal squamous carcinoma and the therapeutic potential of PKP1
Xiuzhi Zhang, Wang Zhi, Yutong Zhao, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Xiuzhi Zhang, Wang Zhi, Yutong Zhao, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Development and validation of a nomogram for prognosis of bone metastatic disease in patients with esophageal squamous cell carcinoma: A retrospective study in the SEER database and China cohort
Bo Huang, Weidong Wang, Fang‐Cai Wu, et al.
Journal of bone oncology (2025), pp. 100683-100683
Open Access
Bo Huang, Weidong Wang, Fang‐Cai Wu, et al.
Journal of bone oncology (2025), pp. 100683-100683
Open Access
TAMing Gliomas: Unraveling the Roles of Iba1 and CD163 in Glioblastoma
Haneya Fuse, Yuqi Zheng, Islam Alzoubi, et al.
Cancers (2025) Vol. 17, Iss. 9, pp. 1457-1457
Open Access
Haneya Fuse, Yuqi Zheng, Islam Alzoubi, et al.
Cancers (2025) Vol. 17, Iss. 9, pp. 1457-1457
Open Access
LSM2 drives glioma progression through alternative splicing dysregulation: a multi-omics approach to identify a potential therapeutic target
Yang Cao, Chang Ge, Wenjie Zhang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Yang Cao, Chang Ge, Wenjie Zhang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Protein Kinases in Phagocytosis: Promising Genetic Biomarkers for Cancer
Sadhika Arumilli, Hengrui Liu
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Sadhika Arumilli, Hengrui Liu
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Bladder cancer biomarkers: current approaches and future directions
Melika Ahangar, Frouzandeh Mahjoubi, Seyed Javad Mowla
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Melika Ahangar, Frouzandeh Mahjoubi, Seyed Javad Mowla
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Analyzing Lipid Metabolism-Related Signaling in Arabidopsis Homologs within the Human Genome Provides Valuable Insights into Clinical and Immunological Biomarkers in Pan-Cancer Alternative Splicing Events
Xiaolin Xie, Xiao Zhu
Next research. (2024), pp. 100125-100125
Closed Access | Times Cited: 1
Xiaolin Xie, Xiao Zhu
Next research. (2024), pp. 100125-100125
Closed Access | Times Cited: 1
Diagnostic and Prognostic Potential of FBXO8 Expression in Kidney Renal Clear Cell Carcinoma and Its Regulation of Renal Adenocarcinoma Cells
Z.W Luo, Xiaoping Wu, Jiang Xie, et al.
Cancer Genetics (2024) Vol. 290-291, pp. 6-15
Closed Access
Z.W Luo, Xiaoping Wu, Jiang Xie, et al.
Cancer Genetics (2024) Vol. 290-291, pp. 6-15
Closed Access